Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001144204-14-019295
Filing Date
2014-03-31
Accepted
2014-03-31 15:04:38
Documents
11

Document Format Files

Seq Description Document Type Size
1 POS AM v372892_posam.htm POS AM 1450849
2 EXHIBIT 5.1 v372892_ex5-1.htm EX-5.1 6439
3 EXHIBIT 23.1 v372892_ex23-1.htm EX-23.1 2373
4 EXHIBIT 23.2 v372892_ex23-2.htm EX-23.2 3748
5 GRAPHIC tsig.jpg GRAPHIC 6362
  Complete submission text file 0001144204-14-019295.txt   7025510

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lpcn-20131231.xml EX-101.INS 1056169
7 XBRL TAXONOMY EXTENSION SCHEMA lpcn-20131231.xsd EX-101.SCH 42941
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lpcn-20131231_cal.xml EX-101.CAL 44032
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lpcn-20131231_def.xml EX-101.DEF 275729
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE lpcn-20131231_lab.xml EX-101.LAB 308826
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lpcn-20131231_pre.xml EX-101.PRE 328949
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-190897 | Film No.: 14729597
SIC: 2834 Pharmaceutical Preparations